文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

碘-125游离籽源迁移是否增加前列腺癌第二恶性肿瘤风险

Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-12-28

该多中心回顾性研究纳入2802例接受碘-125游离籽源近距离治疗的前列腺癌患者,评估籽源迁移与第二恶性肿瘤风险的关系。

要点

  • 籽源迁移发生率9.4%,第二恶性肿瘤发生率3.1%,两组无显著差异。
  • 7年和10年累积发生率在迁移组与非迁移组间均无统计学差异。
  • 仅高龄与第二恶性肿瘤发生显著相关,籽源迁移非显著预测因素。

核心结论

  • 碘-125游离籽源近距离治疗后籽源迁移未显示增加前列腺癌患者第二恶性肿瘤风险。

研究设计与样本

  • 回顾性多中心研究,纳入3个加拿大中心2802例接受碘-125游离籽源近距离治疗的前列腺癌患者。
  • 植入后行盆腔X线摄影和CT扫描评估籽源迁移,通过病历回顾确定第二恶性肿瘤发生。

临床怎么用

  • 对于接受碘-125游离籽源近距离治疗的前列腺癌患者,籽源迁移不应作为第二恶性肿瘤风险的独立担忧因素。

局限性

  • 需要更长的随访时间和更多事件数来更好地关联籽源迁移与第二恶性肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the risk of second malignancies after migration of seeds (MS) in prostate cancer patients treated with 125I loose seeds brachytherapy. METHODS AND MATERIALS: Data from 2802 prostate cancer patients treated with 125I loose seeds brachytherapy in 3 Canadian centers were reviewed. After seeds implant, all patients underwent postimplant pelvic radiography and computed tomography scan for postimplant dosimetry. These images were used to assess whether seed migration occurred. The incidence of second malignancies was determined through the review of patient charts. The 7- and 10-year cumulative incidences of second malignancies and their 95% confidence intervals (CIs) were calculated. Fine and Gray competing risk regression analysis was used to assess the factors associated with the development of second malignancies. RESULTS: Mean age and median follow-up were 63.5 years and 74 (range, 12-246) months, respectively. Migration of seeds occurred in 263 of 2802 patients (9.4%). Second malignancy occurred in 87 patients (3.1%) for the entire cohort and was not different between patients who experienced MS (9, 3.4%) and those who did not (78, 3.1%) (P = .755). The 7-year cumulative incidence rates of second malignancies were 2.95% (95% CI 1.20%-6.00%) (with MS) versus 2.82% (2.10%-3.70%) (without MS) (P = .756). The corresponding values at 10 years were 6.16% (2.20%-12.3%) versus 4.51% (3.20%-5.50%) (P = .570). Migration of seeds did not seem to be a significant predictive factor for second malignancies development (adjusted hazard ratio 1.27 [95% CI 0.63-2.55]; P = .510). In both models, only advanced age was significantly associated with second malignancies development. CONCLUSIONS: These results did not show an increased risk of second malignancies associated with MS after 125I loose seeds brachytherapy for prostate cancer patients. Longer follow-up and more events are required to better correlate MS and second malignancies.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Vigneault E, Martell K, Taussky D, et al. Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy? Int J Radiat Oncol Biol Phys. 2017. PMID: 29428250. doi:10.1016/j.ijrobp.2017.12.273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。